Similar Articles
1341 Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
1342 PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
1343 Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
1344 Pediatric hepatocellular carcinoma
1345 Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
1346 Clinical impact of microbiome in patients with decompensated cirrhosis
1347 Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
1348 Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases
1349 Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
1350 p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA